Press Releases - 2022-08-23

Date	Title	Company
23-Aug-2022	Beckman Coulter Life Sciences Partners with Flownamics on Bioprocess Culture Monitoring Solution	Beckman Coulter Life Sciences
23-Aug-2022	NHS delivering on tech inclusion according to new research	Gemserv
23-Aug-2022	President	Special Public Communications
23-Aug-2022	£10.4m full-service contract signed with existing Big Pharma client	Open Orphan plc
23-Aug-2022	HUTCHMED Highlights Fruquintinib MRCT FRESCO-2 Data to be Presented at the Upcoming ESMO Congress 2022	HUTCHMED
23-Aug-2022	BioInnovation Institute announces new Venture House program and initial intake of four innovative companies	BioInnovation Institute
23-Aug-2022	Innovative Attosecond Optics from Edmund Optics® and UltraFast Innovations Awarded Platinum-Level 2022 LFW Innovators Award!	Ultrafast Innovations GmbH
23-Aug-2022	The health and social work sector offers the fourth best employer pension contributions of any industry	Investing Reviews
23-Aug-2022	CSL Vifor and Travere Therapeutics announce EMA has accepted for review the Conditional Marketing Authorization application for sparsentan for the treatment of IgA Nephropathy	CSL Vifor
23-Aug-2022	ISCT marks bluebird bio’s landmark FDA approval a celebration for the CGT sector while calling industry to attention in the pursuit of patient access	ISCT
23-Aug-2022	Bristol Myers Squibb UK&I is first pharmaceutical company to be accredited as a Menopause Friendly Workplace	Bristol Myers Squibb UK&I
23-Aug-2022	The BioInnovation Institute supports three international start-ups developing pioneering science in the therapeutics and health tech space	The BioInnovation Institute
23-Aug-2022	European Medicines Agency commences review of oral fixed-dose combination of decitabine and cedazuridine for the treatment of adults with acute myeloid leukaemia	Otsuka Pharmaceutical Europe Ltd
23-Aug-2022	Compression Therapy Market value of US$ 3.01 Billion in 2022 and reach US$ 4.59 Billion by 2030	MARKITWIRED
23-Aug-2022	Gene Synthesis Market will expand at an exponential 20% CAGR through 2029	MARKITWIRED
23-Aug-2022	3D Cell Culture Market to attain a valuation of US$ 2.67 Billion by 2031	MARKITWIRED
23-Aug-2022	Dialysis Equipment Market to valuation of US$ 23.62 Million by 2028 \| FMI	MARKITWIRED
23-Aug-2022	Connected Drug Delivery Devices Market is projected to reach US$ 1.6 Billion by 2028	MARKITWIRED
23-Aug-2022	Anaesthesia Machines Market is estimated to be valued at US$ 2.4 Billion by 2028	MARKITWIRED
23-Aug-2022	Cardiac Assist Devices Market is poised to expand at 5.29% CAGR, reaching US$ 2,062.7 Billion by 2031	MARKITWIRED